| EN

第53屆周年會員大會

香港科研製藥聯會於三月廿四日於網上舉行了第53屆周年會員大會。

During the AGM, President Dr Daniel Thurley and Board members presented reports on work over the past year. The Association also unveiled its revamped web site as an interactive platform of knowledge exchange for members.

At the meeting, Ms. Dorine Leung, ex-General Manager of Novartis (HK) Limited, announced her resignation from the role of HKAPI Vice President with effect from today after the AGM. Dorine started serving as a Board member in 2018. During this time, she served and provided her invaluable leadership within different task forces. From 2018- 2020, she guided, motivated and directed the Open Access Task Force to develop the first HKAPI Patient Support Program e-platform – 藥物資助計劃.

The Board thanks Dorine for her dedication and the great job she had accomplished. We wish her all the very best in her future endeavors.

Dorine hosting the HKAPI Patient Support Program survey result sharing session in 2019, which marked the first step in building a collaboration platform for stakeholders to improve patient access through Patient Support Programs

Meanwhile, we are pleased to announce that Ms Kara Cheung (Amgen) was duly elected by the Board as the new Vice President.  Kara is the General Manager of Amgen and has been serving the industry as an HKAPI Board member since 2014. She was our Vice President and President respectively from 2017 to 2020.  

張欣庭女士

Ms Kara Cheung was duly chosen by the Board as the new Vice-President

梁麗萍女士

梁麗萍女士自2020年4月起擔任本會副會長

本會感謝會員參與第53屆周年會員大會,同時感激會員對本會一直以來的支持。 

會長及董事長周年報告已上載至會員專區。

X
Close Bitnami banner
Bitnami